Lucintel Forecasts The Lung Cancer Surgery Market In United States To Reach $6 Billion By 2031

By Author: Lucintel LLC
Total Articles: 5537
Comment this article

According to a market report by Lucintel, the future of the lung cancer surgery market in United States looks promising with opportunities in the hospital, specialty cancer care center, and ambulatory surgical center markets. The lung cancer surgery market in United States is expected to reach an estimated $6 billion by 2031 with a CAGR of 3.4% from 2025 to 2031. The major drivers for this market are the rising occurrence of lung cancer, the increasing consumer preference towards minimally invasive surgeries, and the growing air pollution levels.
A more than 150-page report to understand trends, opportunity and forecast in lung cancer surgery market in United States to 2031 by product type (surgical devices, endosurgical equipment, and monitoring or visualizing equipment), surgery (robotic surgery, thoracotomy, video assisted surgery, percutaneous surgery, and endobronchial surgery), and end use (hospitals, specialty cancer care centers, ambulatory surgical centers, and others).
Download sample by clicking on lung cancer surgery market in United States.
Lucintel forecasts that, within the product type category, ...
... surgical device is expected to witness the highest growth over the forecast period.
Within the end use category, ambulatory surgical center is expected to witness the highest growth over the forecast period.
This unique research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost visit Lucintel's Analytics Dashboard.
About Lucintel
At Lucintel, we offer solutions for you growth through game changer ideas and robust market & unmet needs analysis. We are based in Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20 years. We are quoted in several publications like the Wall Street Journal, ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Lung Cancer Surgery Market in Australia
Lung Cancer Surgery Market in Brazil
Lung Cancer Surgery Market in Canada
Lung Cancer Surgery Market in Mexico
Lung Cancer Surgery Market in Saudi Arabia
Lung Cancer Surgery Market in South Africa